KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer H Alam, M Tang, M Maitituoheti, SS Dhar, M Kumar, CY Han, CR Ambati, ... Cancer cell 37 (4), 599-617. e7, 2020 | 183 | 2020 |
Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 signaling cascades MKY Siu, YX Jiang, JJ Wang, THY Leung, CY Han, BK Tsang, ... Cancers 11 (6), 813, 2019 | 110 | 2019 |
Biomarkers and strategies for early detection of ovarian cancer RC Bast Jr, Z Lu, CY Han, KH Lu, KS Anderson, CW Drescher, SJ Skates Cancer Epidemiology, Biomarkers & Prevention 29 (12), 2504-2512, 2020 | 89 | 2020 |
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling Y Zhang, CY Han, FG Duan, XX Fan, XJ Yao, RJ Parks, YJ Tang, ... Cancer cell international 19, 1-13, 2019 | 64 | 2019 |
Tumor metabolism regulating chemosensitivity in ovarian cancer CY Han, DA Patten, RB Richardson, ME Harper, BK Tsang Genes & cancer 9 (5-6), 155, 2018 | 59 | 2018 |
Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarization, and reactive oxygen species generation through downregulating MLN64 … SD Ha, S Park, CY Han, ML Nguyen, SO Kim Molecular and Cellular Biology, 2012 | 39 | 2012 |
HDAC8-Mediated Epigenetic Reprogramming Plays a Key Role in Resistance to Anthrax Lethal Toxin–Induced Pyroptosis in Macrophages SD Ha, CY Han, C Reid, SO Kim The Journal of Immunology 193 (3), 1333-1343, 2014 | 36 | 2014 |
p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer CY Han, DA Patten, SG Lee, RJ Parks, DW Chan, ME Harper, BK Tsang Molecular Carcinogenesis 58 (11), 2161-2174, 2019 | 33 | 2019 |
Ring finger protein 6 mediates androgen-induced granulosa cell proliferation and follicle growth via modulation of androgen receptor signaling JJ Lim, CY Han, DR Lee, BK Tsang Endocrinology 158 (4), 993-1004, 2017 | 33 | 2017 |
Next steps in the early detection of ovarian cancer RC Bast, CY Han, Z Lu, KH Lu Communications medicine 1 (1), 36, 2021 | 25 | 2021 |
Nuclear HKII-P-p53 (Ser15) interaction is a prognostic biomarker for Chemoresponsiveness and glycolytic regulation in epithelial ovarian Cancer CY Han, DA Patten, SI Kim, JJ Lim, DW Chan, MKY Siu, Y Han, ... Cancers 13 (14), 3399, 2021 | 10 | 2021 |
A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses E Irajizad, CY Han, J Celestino, R Wu, E Murage, R Spencer, ... Clinical Cancer Research 28 (21), 4669-4676, 2022 | 9 | 2022 |
Normal Risk Ovarian Screening Study: 21-Year Update CY Han, KH Lu, G Corrigan, A Perez, SD Kohring, J Celestino, D Bedi, ... Journal of Clinical Oncology 42 (10), 1102-1109, 2024 | 6 | 2024 |
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer C Young Han, JS Bedia, WL Yang, SJ Hawley, L Bergan, M Hopper, ... British journal of cancer 130 (5), 861-868, 2024 | 6 | 2024 |
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers B Kong, CY Han, SI Kim, DA Patten, Y Han, E Carmona, DB Shieh, ... Journal of Ovarian Research 15 (1), 70, 2022 | 6 | 2022 |
The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update. CY Han, KH Lu, D Bedi, E Bedia, TB Bevers, LL Holman, L Leeds, ... Journal of Clinical Oncology 41 (16_suppl), 5522-5522, 2023 | 1 | 2023 |
Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813 MKY Siu, YX Jiang, JJ Wang, THY Leung, CY Han, BK Tsang, ... Cancers 16 (21), 3633, 2024 | | 2024 |
A metabolite-based liquid biopsy for detection of ovarian cancer JF Fahrmann, SM Ghasemi, CY Han, R Wu, JB Dennison, J Vykoukal, ... Biomarker Research 12 (1), 91, 2024 | | 2024 |
Phb1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers B Kong, CY Han, SI Kim, DA Patten, Y Han, E Carmona, DB Shieh, ... | | 2022 |
The Role of Hexokinase II in the Regulation of Glycolysis and Cisplatin Sensitivity in Ovarian Cancer CY Han Université d'Ottawa/University of Ottawa, 2018 | | 2018 |